Market watch: Benefits and costs of immunizing children against influenza at school: An economic analysis based on a large-cluster controlled clinical trial

Jordana Schmier, Su Li, James C. King, Kristin Nichol, Parthiv J. Mahadevia

Research output: Contribution to journalArticle

44 Scopus citations

Abstract

Current influenza vaccination recommendations focus on immunizing high-risk people; however, influenza mortality and morbidity remain elevated. U.S. policymakers are considering expansion of flu vaccination recommendations to include school-age children (ages 5-18). Children are at risk for flu and propagate epidemic spread. Immunizing children at school offers an efficient approach to covering this population. This study examines the cost consequences of a large multistate, school-based influenza immunization program. The results show that immunization reduces disease among children and adults and is cost-saving to society. An epidemiologically based influenza immunization policy might be an important supplement to the existing risk-based policy.

Original languageEnglish (US)
Pages (from-to)w96-w104
JournalHealth Affairs
Volume27
Issue number2
DOIs
StatePublished - Mar 1 2008

Fingerprint Dive into the research topics of 'Market watch: Benefits and costs of immunizing children against influenza at school: An economic analysis based on a large-cluster controlled clinical trial'. Together they form a unique fingerprint.

Cite this